Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in Eastern Saudi Arabia

Naglaa A. Fawaz, Hala Tamim, Wassim Y. Almawi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The seroprevalence of human T-lymphotropic virus (HTLV)-I/II was assessed in 13,443 consecutive blood donors in eastern Saudi Arabia between 1998 and 2001. Screening by enzyme-linked immunosorbent assay (ELISA) and confirmation by Western blot resulted in 8 (0.060%) positive cases, of which 5 (0.056%) belonged to Saudi and 3 (0.113%) to non-Saudi donors. The majority of the HTLV-positive donations (6/8) were for patients, and none had a history of known risk factor for HTLV-I/II transmission. Although the very low prevalence of HTLV-I/II among Saudi donors does not support routine screening, screening of donors from other nationalities may be initiated, especially those from HTLV-I/II endemic areas.

Original languageEnglish
Pages (from-to)189-191
Number of pages3
JournalAmerican Journal of Infection Control
Volume33
Issue number3
DOIs
Publication statusPublished - Apr 2005

Fingerprint

Human T-lymphotropic virus 2
Saudi Arabia
Blood Donors
Antibodies
Tissue Donors
Donor Selection
Seroepidemiologic Studies
Ethnic Groups
Western Blotting
Enzyme-Linked Immunosorbent Assay
Viruses

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in Eastern Saudi Arabia. / Fawaz, Naglaa A.; Tamim, Hala; Almawi, Wassim Y.

In: American Journal of Infection Control, Vol. 33, No. 3, 04.2005, p. 189-191.

Research output: Contribution to journalArticle

@article{28a3a975a08b4d5598cae08159826ab5,
title = "Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in Eastern Saudi Arabia",
abstract = "The seroprevalence of human T-lymphotropic virus (HTLV)-I/II was assessed in 13,443 consecutive blood donors in eastern Saudi Arabia between 1998 and 2001. Screening by enzyme-linked immunosorbent assay (ELISA) and confirmation by Western blot resulted in 8 (0.060{\%}) positive cases, of which 5 (0.056{\%}) belonged to Saudi and 3 (0.113{\%}) to non-Saudi donors. The majority of the HTLV-positive donations (6/8) were for patients, and none had a history of known risk factor for HTLV-I/II transmission. Although the very low prevalence of HTLV-I/II among Saudi donors does not support routine screening, screening of donors from other nationalities may be initiated, especially those from HTLV-I/II endemic areas.",
author = "Fawaz, {Naglaa A.} and Hala Tamim and Almawi, {Wassim Y.}",
year = "2005",
month = "4",
doi = "10.1016/j.ajic.2004.08.006",
language = "English",
volume = "33",
pages = "189--191",
journal = "American Journal of Infection Control",
issn = "0196-6553",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in Eastern Saudi Arabia

AU - Fawaz, Naglaa A.

AU - Tamim, Hala

AU - Almawi, Wassim Y.

PY - 2005/4

Y1 - 2005/4

N2 - The seroprevalence of human T-lymphotropic virus (HTLV)-I/II was assessed in 13,443 consecutive blood donors in eastern Saudi Arabia between 1998 and 2001. Screening by enzyme-linked immunosorbent assay (ELISA) and confirmation by Western blot resulted in 8 (0.060%) positive cases, of which 5 (0.056%) belonged to Saudi and 3 (0.113%) to non-Saudi donors. The majority of the HTLV-positive donations (6/8) were for patients, and none had a history of known risk factor for HTLV-I/II transmission. Although the very low prevalence of HTLV-I/II among Saudi donors does not support routine screening, screening of donors from other nationalities may be initiated, especially those from HTLV-I/II endemic areas.

AB - The seroprevalence of human T-lymphotropic virus (HTLV)-I/II was assessed in 13,443 consecutive blood donors in eastern Saudi Arabia between 1998 and 2001. Screening by enzyme-linked immunosorbent assay (ELISA) and confirmation by Western blot resulted in 8 (0.060%) positive cases, of which 5 (0.056%) belonged to Saudi and 3 (0.113%) to non-Saudi donors. The majority of the HTLV-positive donations (6/8) were for patients, and none had a history of known risk factor for HTLV-I/II transmission. Although the very low prevalence of HTLV-I/II among Saudi donors does not support routine screening, screening of donors from other nationalities may be initiated, especially those from HTLV-I/II endemic areas.

UR - http://www.scopus.com/inward/record.url?scp=15744386944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15744386944&partnerID=8YFLogxK

U2 - 10.1016/j.ajic.2004.08.006

DO - 10.1016/j.ajic.2004.08.006

M3 - Article

VL - 33

SP - 189

EP - 191

JO - American Journal of Infection Control

JF - American Journal of Infection Control

SN - 0196-6553

IS - 3

ER -